Effect of minocycline and doxycycline on IgE responses

Annals of Allergy, Asthma and Immunology

Volumn 89, Issue 2, 2002, Pages 172-179

  Smith Norowitz, Tamar A ^a   Bluth, Martin H ^a   Drew, Hazel ^a   Norowitz, Kevin B ^a   Chice, Seto ^a   Shah, Vipin N ^a   Nowakowski, Maja ^a   Josephson, Alan S ^a   Durkin, Helen G ^a   Joks, Rauno ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CD8 ANTIGEN; DOXYCYCLINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; MINOCYCLINE; PREDNISONE; RECOMBINANT INTERLEUKIN 4; STEROID; TETRACYCLINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE; MALE; MONONUCLEAR CELL; NEPHELOMETRY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036706797     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61934-5     Document Type: Article

References (39)

1. Djukanovic R. Asthma: a disease of inflammation and repair. J Allergy Clin Immunol 2000;105:S522-S526.
2. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
3. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344: 350-362.
4. Romagnani S. Role of Th2 lymphocytes in the genesis of allergic disorders and mechanisms involved in their development. Asthma, Physiology, and Immunopharmacology, Fourth International Symposium. New York: Harcourt, Brace & Company Publishers, 1993:163-172.
5. Djukanovic R, Wilson JW, Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of atopic asthmatic and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990;142:863-871.
6. Joks R, Daoud A, Orloff K, et al. Minocycline as an antiinflammatory agent in the treatment of asthma. J Allergy Clin Immunol 1998;101:S62.
7. O'Dell JR, Haire CE, Palmer W, et al. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled study. Arthritis Rheum 1997;40:842-848.
8. O'Dell JR, Paulsen G, Haire CE, et al. Treatment of early seropositive rheumatoid arthritis with minocycline: four year followup of a double-blind, placebo controlled trial. Arthritis Rheum 1999;42:1691-1695.
9. Yu LP, Smith GN, Brandt KD, et al. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992;35:1150-1155.
10. Thong YH, Ferrante A. Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol 1979;35:443-446.
11. Ingham E, Turnbull L, Kearney JN. The effects of minocycline and tetracycline on the mitotic response of human peripheral blood-lymphocytes. J Antimicrob Chemother 1991;27: 607-617.
12. Amin AR, Attur MG, Thakker GD, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA 1996;93:14014-14019.
13. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health; April 1997; Publication no 97-4051.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
15. Sampson HA, Buckley RH. Human IgE synthesis in vitro: a reassessment. J Immunol 1981;127:829-834.
16. Holt PG, Sly PD. γδ T cells provide a breath of fresh air for asthma research. Nat Med 1999;5:1127-1128.
17. Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma. Am Rev Respir Dis 1990;141:970-975.
18. Gonzalez MC, Diaz P, Galleguillos FR, et al. Allergen-induced recruitment of bronchoalveolar helper cells (OKT4) and suppressor (OKT8) T-cells in asthma. Relative increases in OKT8 cells in single early responders compared with those in latephase responders. Am Rev Respir Dis 1987;136:600-604.
19. Walker C, Bode E, Boer L, et al. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-115.
20. Schwarze J, Makela M, Cieslewicz G, et al. Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes. J Immunol 1999;163:5729-5734.
21. McMenamin C, Holt PG. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med 1993;178:889-899.
22. Janssen EM, van Ooserhout AJ, van Rensen AJ, et al. Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide. J Immunol 2000;164:580-588.
23. Holgate S, Bradding P, Sampson AP. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 1996;98:1-13.
24. Barnes PJ. Frontiers in medicine: new aspects of asthma. J Intern Med 1992;231:453-461.
25. Henderson WR Jr, Chi EY, Maliszewshi CR. Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J Immunol 2000;164: 1086-1095.
26. Zurawski G, deVries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B-cells, but not on T cells. Immunol Today 1994;15:19-26.
27. Herrick CA, Carucci JA, Kleiner GI, Durkin HG. Regulation of hapten-specific memory IgE responses induced in vitro. Requirement for Thy-1 + AsGM1 + and Thy-1 + AsGM1-cells and for IFN-α and IL-4. J Immunol 1993;151:3440-3449.
28. Punnonen J, Punnonen K, Jansen CT, Kalimo K. Interferon (IFN)-α, IFN-γ, interleukin (IL)-2, and arachidonic acid metabolites modulate IL-4-induced IgE synthesis similarly in healthy persons and in atopic dermatitis patient. Allergy 1993;48: 189-195.
29. Cocks BG, de Waal Malefyt R, Galizzi JP, et al. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Internat Immunol 1993;5:657-663.
30. Smith-Norowitz TA. Role of CD8+CD60+ T cells in peripheral blood of atopic humans in regulation of allergic (IgE) responses [dissertation]. SUNY Health Science Center, Brooklyn, NY; 1997.
31. Smith-Norowitz TA, Auci DL, Norowitz KB, et al. CD8+CD60+ T cells as regulators of human allergic (IgE) responses. J Allergy Clin Immunol 1997;99(Suppl):S96.
32. Vukmanovic-Stejic, M, Vyas B. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood 2000;95:231-240.
33. Carucci JA, Auci DL, Herrick CA, Durkin HG. Neuropeptidemediated regulation of hapten-specific IgE responses in mice. I. Substance P-mediated isotype-specific suppression of BPOspecific IgE antibody-forming cell responses induced in vivo and in vitro. J Leukoc Biol 1995;57:110-115.
34. Auci DL, Carucci JA, Chice SM, et al. Control of IgE responses. 4. Isotype-specific suppression of peak BPO-specific IgE antibodyforming cell responses and of BPO-specific IgE in serum by muramyldipeptide or murabutide after administration to mice by gavage. Int Arch Allergy Immunol 1993;101:167-176.
35. MacGlashan D, Bochner B, Adelman D, et al. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-1445.
36. Kimata H, Yoshida A, Ishioka C, et al. Interleukin-8 selectively inhibits immunoglobulin E production induced by IL-4 in human B cells. J Exp Med 1992;176:1227-1231.
37. Gauchat J-F, Aversa G, Gascan H, et al. Modulation of IL-4 induced germline ε RNA synthesis in human B cells by tumor necrosis factor-α, anti-CD40 monoclonal antibodies or transforming growth factor-β correlates with levels of IgE production. Int Immunol 1992;4:397-406.
38. Gauchat J-F, Lebman DA, Coffman RL, et al. Structure and expression of germline E transcripts in human B cells induced by interleukin-4 switch to IgE production. J Exp Med 1990;172: 463-473.
39. Kiniwa M, Gately M, Gubler U, et al. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J Clin Invest 1992;90: 262-266.